FcRn: From molecular interactions to regulation of IgG pharmacokinetics and functions

Current Topics in Microbiology and Immunology

Volumn 382, Issue , 2014, Pages 249-272

  Challa, Dilip K ^a   Velmurugan, Ramraj ^a   Ober, Raimund J ^a,b   Ward, E Sally ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b The University of Texas at Dallas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; SYN 1436; UNCLASSIFIED DRUG; ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSPORT; DEGRADATION KINETICS; DRUG HALF LIFE; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; PH MEASUREMENT; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TRANSCYTOSIS; ANTIBODY ENGINEERING; ARTICLE; HALF LIFE TIME; IMMUNE RESPONSE; MOLECULAR BIOLOGY; MOLECULARLY TARGETED THERAPY; PH; PHARMACOKINETICS; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN TRANSPORT;

ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEOSTASIS; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, FC;

EID: 84958543989     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-319-07911-0_12     Document Type: Review

References (142)

1. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41-53
2. Abuqayyas L, Balthasar JP (2013) Investigation of the role of FcγR and FcRn in mAb distribution to the brain. Mol Pharm 10(5):1505-1513
3. Agola JO, Jim PA, Ward HH et al (2011) Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet 80(4):305-318
4. Akilesh S, Christianson GJ, Roopenian DC et al (2007) Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 179(7):4580-4588
5. Akilesh S, Huber TB, Wu H et al (2008) Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci USA 105(3):967-972
6. Andersen JT, Dee Qian J, Sandlie I (2006) The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. Eur J Immunol 36(11):3044-3051
7. Andersen JT, Foss S, Kenanova VE et al (2012) Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. J Biol Chem 287(27):22927-22937
8. Antohe F, Radulescu L, Gafencu A et al (2001) Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol 62(2):93-105
9. Appleby P, Catty D (1983) Transmission of immunoglobulin to foetal and neonatal mice. J Reprod Immunol 5(4):203-213
10. Asano K, Nabeyama A, Miyake Y et al (2011) CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34(1):85-95
11. Baker K, Qiao SW, Kuo TT et al (2011) Neonatal Fc receptor for IgG (FcRn) regulates crosspresentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci USA 108(24):9927-9932
12. Borvak J, Richardson J, Medesan C et al (1998) Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int Immunol 10(9):1289-1298
13. Brambell FWR (1970) The transmission of passive immunity from mother to young. North Holland Publ Corp, Amsterdam
14. Bry L, Brenner MB (2004) Critical role of T cell-dependent serum antibody, but not the gutassociated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 172(1):433-441
15. Cauza K, Hinterhuber G, Ngelmaier-Hovorka R et al (2005) Expression of FcRn, the MHC class I-related receptor for IgG, in human keratinocytes. J Invest Dermatol 124(1):132-139
16. Challa DK, Bussmeyer U, Khan T et al (2013) Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis. MAbs 5(5):655-659
17. Chan AC, Carter PJ (2010) Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 10(5):301-316
18. Chaudhury C, Mehnaz S, Robinson JM et al (2003) The major histocompatibility complexrelated Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197(3):315-322
19. Christianson GJ, Sun VZ, Akilesh S et al (2012) Monoclonal antibodies directed against human FcRn and their applications. MAbs 4(2)
20. Cianga P, Cianga C, Cozma L et al (2003) The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland. Hum Immunol 64(12):1152-1159
21. Claypool SM, Dickinson BL, Wagner JS et al (2004) Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fc-c receptor. Mol Biol Cell 15:1746-1759
22. Claypool SM, Dickinson BL, Yoshida M et al (2002) Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin. J Biol Chem 277(31):28038-28050
23. Colvin RB, Smith RN (2005) Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5(10):807-817
24. Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116(11):2843-2854
25. Cooper PR, Ciambrone GJ, Kliwinski CM et al (2013) Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn. Brain Res 1534:13-21
26. Dall'Acqua W, Woods RM, Ward ES et al (2002) Increasing the affinity of a human IgG1 to the neonatal Fc receptor: biological consequences. J Immunol 169(9):5171-5180
27. Dall'Acqua WF, Kiener PA, Wu H (2006) Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem 281(33):23514-23524
28. Dati F, Schumann G, Thomas L et al (1996) Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International federation of clinical chemistry. Community bureau of reference of the commission of the European communities. College of American pathologists. Eur J Clin Chem Clin Biochem 34(6):517-520
29. Deane R, Sagare A, Hamm K et al (2005) IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. J Neurosci 25(50):11495-11503
30. Dickinson BL, Badizadegan K, Wu Z et al (1999) Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest 104(7):903-911
31. Dickinson BL, Claypool SM, D'Angelo JA et al (2008) Ca2 + -dependent calmodulin binding to FcRn affects immunoglobulin G transport in the transcytotic pathway. Mol Biol Cell 19(1):414-423
32. Firan M, Bawdon R, Radu C et al (2001) The MHC class I related receptor, FcRn, plays an essential role in the maternofetal transfer of gammaglobulin in humans. Int Immunol 13:993-1002
33. Fox SI (2011) Human physiology, 12th edn. McGraw-Hill, New York, pp 577-585
34. Gan Z, Ram S, Ober RJ et al (2013) Using multifocal plane microscopy to reveal novel trafficking processes in the recycling pathway. J Cell Sci 126(Pt 5):1176-1188
35. Gan Z, Ram S, Vaccaro C et al (2009) Analyses of the recycling receptor, FcRn, in live cells reveal novel pathways for lysosomal delivery. Traffic 10(5):600-614
36. Garg A, Balthasar JP (2009) Investigation of the influence of FcRn on the distribution of IgG to the brain. AAPS J 11(3):553-557
37. Getman KE, Balthasar JP (2005) Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions. J Pharm Sci 94(4):718-729
38. Ghetie V, Hubbard JG, Kim JK et al (1996) Abnormally short serum half-lives of IgG in beta 2- microglobulin-deficient mice. Eur J Immunol 26(3):690-696
39. Ghetie V, Popov S, Borvak J et al (1997) Increasing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol 15(7):637-640
40. Guilliams M, Bruhns P, Saeys Y et al (2014) The function of Fcc receptors in dendritic cells and macrophages. Nat Rev Immunol 14(2):94-108
41. Gupta S, Gach JS, Becerra JC et al (2013) The neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog 9(11):e1003776
42. Hammer JA 3rd, Sellers JR (2012) Walking to work: roles for class V myosins as cargo transporters. Nat Rev Mol Cell Biol 13(1):13-26
43. Hansen RJ, Balthasar JP (2002) Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. Blood 100(6):2087-2093
44. Hanson LA, Brandzaeg P (1980) The mucosal defense system. In: Stiehm ER, Fulginity VA (eds) Immunologic disorders in infants and children. 2nd edn. Saunder WB, Philadelphia, pp 137-164
45. Haymann JP, Levraud JP, Bouet S et al (2000) Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol 11(4):632-639
46. Heatwole C, Johnson N, Holloway R et al (2011) Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study. J Clin Neuromuscul Dis 13(2):85-94
47. Hildner K, Edelson BT, Purtha WE et al (2008) Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322(5904):1097-1100
48. Hinton PR, Johlfs MG, Xiong JM et al (2004) Engineered human IgG antibodies with longer serum half-lives in primates. J Biol Chem 279(8):6213-6216
49. Hinton PR, Xiong JM, Johlfs MG et al (2006) An engineered human IgG1 antibody with longer serum half-life. J Immunol 176(1):346-356
50. Hogarth PM, Pietersz GA (2012) Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov 11(4):311-331
51. Houde M, Bertholet S, Gagnon E et al (2003) Phagosomes are competent organelles for antigen cross-presentation. Nature 425(6956):402-406
52. Israel EJ, Taylor S, Wu Z et al (1997) Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92(1):69-74
53. Israel EJ, Wilsker DF, Hayes KC et al (1996) Increased clearance of IgG in mice that lack beta 2- microglobulin: possible protective role of FcRn. Immunology 89(4):573-578
54. Jahn R, Lang T, Sudhof TC (2003) Membrane fusion. Cell 112(4):519-533
55. Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6(7):383-392
56. Johansson M, Lycke NY (2003) Immunology of the human genital tract. Curr Opin Infect Dis 16(1):43-49
57. Jones EA, Waldmann TA (1972) The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest 51(11):2916-2927
58. Junghans RP, Anderson CL (1996) The protection receptor for IgG catabolism is the beta2- microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 93(11):5512-5516
59. Kim H, Fariss RN, Zhang C et al (2008) Mapping of the neonatal Fc receptor in the rodent eye. Invest Ophthalmol Vis Sci 49(5):2025-2029
60. Kim JK, Firan M, Radu CG et al (1999) Mapping the site on human IgG for binding of the MHC class I-related receptor. FcRn. Eur J Immunol 29(9):2819-2825
61. Kobayashi K, Qiao SW, Yoshida M et al (2009) An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice. Gastroenterology 137(5):1746-1756 e1741
62. Kobayashi N, Suzuki Y, Tsuge T et al (2002) FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells. Am J Physiol Renal Physiol 282(2):F358-F365
63. Kozlowski PA, Cu-Uvin S, Neutra MR et al (1997) Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 65(4):1387-1394
64. Kuo TT, Baker K, Yoshida M et al (2010) Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 30(6):777-789
65. Kuo TT, de Muinck EJ, Claypool SM et al (2009) N-Glycan moieties in neonatal Fc receptor determine steady-state membrane distribution and directional transport of IgG. J Biol Chem 284(13):8292-8300
66. Kurts C, Robinson BW, Knolle PA (2010) Cross-priming in health and disease. Nat Rev Immunol 10(6):403-414
67. Leach JL, Sedmak DD, Osborne JM et al (1996) Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal- fetal antibody transport. J Immunol 157(8):3317-3322
68. Li N, Zhao M, Hilario-Vargas J et al (2005) Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest 115(12):3440-3450
69. Li Z, Palaniyandi S, Zeng R et al (2011) Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci USA 108(11):4388-4393
70. Liu L, Garcia AM, Santoro H et al (2007a) Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade. J Immunol 178(8):5390-5398
71. Liu X, Ye L, Bai Y et al (2008) Activation of the JAK/STAT-1 signaling pathway by IFN-c can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG. J Immunol 181(1):449-463
72. Liu X, Ye L, Christianson GJ et al (2007b) NF-kappaB signaling regulates functional expression of the MHC class I-related neonatal Fc receptor for IgG via intronic binding sequences. J Immunol 179(5):2999-3011
73. Mahmud N, Klipa D, Ahsan N (2010) Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs 2(2):148-156
74. Martin MG, Wu SV, Walsh JH (1997) Ontogenetic development and distribution of antibody transport and Fc receptor mRNA expression in rat intestine. Dig Dis Sci 42(5):1062-1069
75. Martin WL, West AP Jr, Gan L et al (2001) Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH dependent binding. Mol Cell 7(4):867-877
76. McGhee JR, Fujihashi K (2012) Inside the mucosal immune system. PLoS Biol 10(9):e1001397
77. Medesan C, Matesoi D, Radu C et al (1997) Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J Immunol 158(5):2211-2217
78. Medesan C, Radu C, Kim JK et al (1996) Localization of the site of the IgG molecule that regulates maternofetal transmission in mice. Eur J Immunol 26(10):2533-2536
79. Mezo AR, Low SC, Hoehn T et al (2011) PEGylation enhances the therapeutic potential of peptide antagonists of the neonatal Fc receptor FcRn. Bioorg Med Chem Lett 21(21): 6332-6335
80. Mezo AR, McDonnell KA, Hehir CA et al (2008) Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc Natl Acad Sci USA 105(7):2337-2342
81. Miaczynska M, Zerial M (2002) Mosaic organization of the endocytic pathway. Exp Cell Res 272(1):8-14
82. Naparstek Y, Plotz PH (1993) The role of autoantibodies in autoimmune disease. Annu Rev Immunol 11:79-104
83. Neefjes J, Jongsma ML, Paul P et al (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11(12):823-836
84. Newton EE, Wu Z, Simister NE (2005) Characterization of basolateral-targeting signals in the neonatal Fc receptor. J Cell Sci 118(Pt 11):2461-2469
85. Nimmerjahn F, Ravetch JV (2008) Fcc receptors as regulators of immune responses. Nat Rev Immunol 8(1):34-47
86. Ober RJ, Martinez C, Lai X et al (2004a) Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level. Proc Natl Acad Sci USA 101:11076-11081
87. Ober RJ, Martinez C, Vaccaro C et al (2004b) Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor. FcRn. J Immunol 172(4):2021-2029
88. Oganesyan V, Damschroder MM, Cook KE et al (2014) Structural insights Into neonatal Fc receptor-based recycling mechanisms. J Biol Chem 289(11):7812-7824
89. Orange JS, Hossny EM, Weiler CR et al (2006) Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency committee of the American academy of allergy, asthma and immunology. J Allergy Clin Immunol 117(4 Suppl):S525-S553
90. Patel DA, Puig-Canto A, Challa DK et al (2011) Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model. J Immunol 187(2):1015-1022
91. Pavenstadt H, Kriz W, Kretzler M (2003) Cell biology of the glomerular podocyte. Physiol Rev 83(1):253-307
92. Perez-Montoyo H, Vaccaro C, Hafner M et al (2009) Conditional deletion of the MHC Class Irelated receptor, FcRn, reveals the sites of IgG homeostasis in mice. Proc Natl Acad Sci USA 106(8):2788-2793
93. Popescu BF, Lucchinetti CF (2012) Pathology of demyelinating diseases. Annu Rev Pathol 7:185-217
94. Popov S, Hubbard JG, Kim J et al (1996) The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor. FcRn. Mol Immunol 33(6):521-530
95. Powner MB, McKenzie JA, Christianson GJ et al (2014) Expression of neonatal Fc receptor in the eye. Invest Ophthalmol Vis Sci 55(3):1607-1615
96. Prabhat P, Gan Z, Chao J et al (2007) Elucidation of intracellular recycling pathways leading to exocytosis of the Fc receptor, FcRn, by using multifocal plane microscopy. Proc Natl Acad Sci USA 104(14):5889-5894
97. Qiao SW, Kobayashi K, Johansen FE et al (2008) Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci USA 105(27):9337-9342
98. Raghavan M, Bonagura VR, Morrison SL et al (1995) Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry 34(45):14649-14657
99. Raghavan M, Gastinel LN, Bjorkman PJ (1993) The class I major histocompatibility complexrelated Fc receptor shows pH-dependent stability differences correlating with immunoglobulin binding and release. Biochemistry 32(33):8654-8660
100. Reichert JM (2013) Which are the antibodies to watch in 2013? MAbs 5(1):1-4
101. Rodewald R, Abrahamson DR (1982) Receptor-mediated transport of IgG across the intestinal epithelium of the neonatal rat. Ciba Found Symp 92:209-232
102. Rodewald R, Kraehenbuhl JP (1984) Receptor-mediated transport of IgG. J Cell Biol 99(1 Pt 2):159s-164s
103. Roopenian DC, Akilesh S (2007) FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7(9):715-725
104. Roopenian DC, Christianson GJ, Sproule TJ et al (2003) The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol 170(7):3528-3533
105. Russo LM, Sandoval RM, McKee M et al (2007) The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 71(6):504-513
106. Salimonu LS, Ladipo OA, Adeniran SO et al (1978) Serum immunoglobulin levels in normal, premature and postmature newborns and their mothers. Int J Gynaecol Obstet 16(2):119-123
107. Sanchez LM, Penny DM, Bjorkman PJ (1999) Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand. Biochemistry 38(29):9471-9476
108. Sarav M, Wang Y, Hack BK et al (2009) Renal FcRn reclaims albumin but facilitates elimination of IgG. J Am Soc Nephrol 20(9):1941-1952
109. Schlachetzki F, Zhu C, Pardridge WM (2002) Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem 81(1):203-206
110. Schuck P, Radu CG, Ward ES (1999) Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1. Mol Immunol 36(15-16):1117-1125
111. Schulz O, Jaensson E, Persson EK et al (2009) Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 206(13):3101-3114
112. Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12(4):278-287
113. Sherer Y, Gorstein A, Fritzler MJ et al (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34(2):501-537
114. Shields RL, Namenuk AK, Hong K et al (2001) High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR. J Biol Chem 276(9):6591-6604
115. Simister NE, Mostov KE (1989) An Fc receptor structurally related to MHC class I antigens. Nature 337(6203):184-187
116. Simister NE, Story CM, Chen HL et al (1996) An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol 26(7):1527-1531
117. Simmons DP, Wearsch PA, Canaday DH et al (2012) Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. J Immunol 188(7):3116-3126
118. Somsel RJ, Wandinger-Ness A (2000) Rab GTPases coordinate endocytosis. J Cell Sci 113(Pt 2):183-192
119. Spiegelberg HL, Fishkin BG (1972) The catabolism of human G immunoglobulins of different heavy chain subclasses. 3. The catabolism of heavy chain disease proteins and of Fc fragments of myeloma proteins. Clin Exp Immunol 10(4):599-607
120. Spiekermann GM, Finn PW, Ward ES et al (2002) Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med 196(3):303-310
121. Stenmark H (2009) Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10(8):513-525
122. Tesar DB, Tiangco NE, Bjorkman PJ (2006) Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic 7(9):1127-1142
123. Tzaban S, Massol RH, Yen E et al (2009) The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity. J Cell Biol 185(4):673-684
124. Vaccaro C, Bawdon R, Wanjie S et al (2006) Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Proc Natl Acad Sci USA 103(49):18709-18714
125. Vaccaro C, Zhou J, Ober RJ et al (2005) Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol 23(10):1283-1288
126. van Bilsen K, Bastiaans J, Dik WA et al (2010) The neonatal Fc receptor is expressed by human lymphocytes. J Transl Med 8(Suppl 1):P1
127. Vieira P, Rajewsky K (1988) The half-lives of serum immunoglobulins in adult mice. Eur J Immunol 18(2):313-316
128. Wang W, Wang EQ, Balthasar JP (2008) Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 84(5):548-558
129. Wani MA, Haynes LD, Kim J et al (2006) Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene. Proc Natl Acad Sci USA 103(13):5084-5089
130. Ward ES, Martinez C, Vaccaro C et al (2005) From sorting endosomes to exocytosis: association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling. Mol Biol Cell 16(4):2028-2038
131. Ward ES, Ober RJ (2009) Multitasking by exploitation of intracellular transport functions: the many faces of FcRn. Adv Immunol 103:77-115
132. Wartiovaara J, Ofverstedt LG, Khoshnoodi J et al (2004) Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 114(10):1475-1483
133. Winters JL (2012) Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematol Am Soc Hematol Educ Program 2012:7-12
134. Winters JL, Brown D, Hazard E et al (2011) Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barre syndrome. BMC Health Serv Res 11:101
135. Woof JM, Mestecky J (2005) Mucosal immunoglobulins. Immunol Rev 206:64-82
136. Ye L, Liu X, Rout SN et al (2008) The MHC class II-associated invariant chain interacts with the neonatal Fcc receptor and modulates its trafficking to endosomal/lysosomal compartments. J Immunol 181(4):2572-2585
137. Yeung YA, Leabman MK, Marvin JS et al (2009) Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates. J Immunol 182(12):7663-7671
138. Yoshida M, Claypool SM, Wagner JS et al (2004) Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20(6):769-783
139. Yoshida M, Kobayashi K, Kuo TT et al (2006) Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 116(8):2142-2151
140. Zalevsky J, Chamberlain AK, Horton HM et al (2010) Enhanced antibody half-life improves in vivo activity. Nat Biotechnol 28(2):157-159
141. Zhang Y, Pardridge WM (2001) Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol 114(1-2):168-172
142. Zhu X, Meng G, Dickinson BL et al (2001) MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 166(5):3266-3276